Jerry S. Lanchbury - Jan 14, 2022 Form 4 Insider Report for MYRIAD GENETICS INC (MYGN)

Role
Officer
Signature
By: Nathan A. Smith For: Jerry S. Lanchbury
Stock symbol
MYGN
Transactions as of
Jan 14, 2022
Transactions value $
$0
Form type
4
Date filed
1/18/2022, 04:02 PM
Previous filing
Oct 12, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding MYGN Common Stock 264K Jan 14, 2022 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Jerry S. Lanchbury is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Remarks:

Mr. Lanchbury's title is Former Chief Scientific Officer This "Exit" Form 4 is voluntarily filed to report solely that the Reporting Person is no longer serving in the role as the Company's Chief Scientific Officer, effective as of January 14, 2022, and therefore is no longer subject to Section 16 reporting